Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -1.00 (-2.38%)
Spread: 2.00 (5.00%)
Open: 42.00
High: 42.00
Low: 41.00
Prev. Close: 42.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights and Director/PDMR Shareholding

21 Nov 2018 11:00

RNS Number : 0841I
Frontier IP Group plc
21 November 2018
 

21 November 2018

 

Frontier IP Group plc

("Frontier IP" or the "Company")

 

Total Voting Rights and Director/PDMR Shareholdings

 

Frontier IP, which specialises in commercialising university intellectual property, announces that the 3,827,852 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") issued pursuant to the placing announced on 15 November 2018 (the "Placing") have today been admitted to trading on AIM ("Admission") and the Placing has completed. The Company's issued share capital now consists of 42,106,372 Ordinary Shares with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 42,106,372.

 

This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Director/PDMR Shareholdings

 

Michael Bourne, Non-Executive Director of the Company, subscribed for 32,932 Ordinary Shares in the Placing at a price of 65 pence per share and now holds a total interest in 303,170 Ordinary Shares, equivalent to 0.72 per cent. of the Company's enlarged ordinary share capital. Details of this purchase were included in the announcement on 15 November 2018.

 

Following Admission, the Directors' beneficial shareholdings are as follows:

 

 

Director

Interest in Ordinary Shares upon Admission

Percentage of voting rights in the Company upon Admission

Andrew Richmond (Non-executive Chairman)

1,000,000

2.37

Neil Crabb (Chief Executive Officer)

2,834,168

6.73

James Fish (Finance Director)

100,000

0.23

Jacqueline McKay (Chief Operating Officer)

12,855

0.03

David Cairns (Portfolio Director)

840,238

1.99

Michael Bourne (Non-executive Director)

303,170

0.72

Campbell Wilson (Non-executive Director)

-

-

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Bourne

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65.00p

32,932

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

21 November 2018

f)

Place of the transaction

Outside a Trading Venue - placing of new ordinary shares

 

The information set out in this announcement is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

Enquiries:

Frontier IP Group plc

T: 0131 240 1251

Neil Crabb, Chief Executive

 

Andrew Johnson, Communications & Investor Relations

M: 07464 546 025

www.frontierip.co.uk

 

 

 

Allenby Capital Limited (Nominated Adviser and Broker)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers (Corporate Finance)

 

Amrit Nahal (Equity Sales)

 

Notes to Editors:

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. The group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKMMZMGMDGRZM
Date   Source Headline
23rd Mar 20173:27 pmRNSHolding(s) in Company
23rd Mar 20173:26 pmRNSHolding(s) in Company
23rd Mar 20173:25 pmRNSHolding(s) in Company
17th Mar 201712:10 pmRNSPlacing to raise £3 million
8th Feb 20177:00 amRNSChange of Adviser
23rd Dec 201611:45 amRNSResult of AGM
7th Dec 20167:00 amRNSNew Portfolio Company - Tarsis Technology Limited
28th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
21st Nov 20167:00 amRNSAudited final results for year ended 30 June 2016
4th Nov 201611:00 amRNSALUSID Wins Prestigious IChemE Award
14th Sep 201611:50 amRNSAgreement with FCT, Universidade NOVA de Lisboa
5th Sep 20167:00 amRNSNandi Proteins Participant in £1m Funding Award
27th Apr 20167:00 amRNSex scientia Limited - Partnership with Evotec AG
11th Apr 20163:31 pmRNSHolding(s) in Company
7th Apr 20167:05 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSGrant of Options
31st Mar 20168:30 amRNSHolding(s) in Company
30th Mar 20169:00 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSEquity Placing raising £1.0M & Total Voting Rights
9th Mar 20167:00 amRNSHalf-year results for the 6 months to 31 Dec 2015
7th Mar 20167:00 amRNSNandi Proteins Ltd: Further Successful Fundraising
8th Feb 20167:00 amRNSAgreement with first Portuguese University
21st Dec 201512:16 pmRNSResult of AGM
7th Dec 20157:00 amRNSAlusid wins prestigious Product of the Year award
1st Dec 20157:00 amRNSHolding(s) in Company
30th Nov 20154:20 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSPosting of Annual Report and Notice of AGM
19th Nov 20157:00 amRNSPreliminary results for year ended 30 June 2015
27th Oct 20157:00 amRNSPortfolio Company Fundraising - PulsiV Solar Ltd
14th Sep 20157:00 amRNSHolding(s) in Company
14th Sep 20157:00 amRNSHolding(s) in Company
24th Jul 20152:18 pmRNSHolding(s) in Company
10th Jul 20158:30 amRNSHolding(s) in Company
14th Apr 20157:00 amRNSHolding(s) in Company
10th Apr 20157:00 amRNSPlacing of new shares
31st Mar 20157:00 amRNSHalf Yearly Report
25th Mar 201510:52 amRNSPortfolio company, Alusid - First Fundraising
11th Mar 20157:00 amRNSKey development at portfolio company PulsiV Solar
10th Mar 20157:03 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSNew advisory client, Vertequip
2nd Mar 20157:00 amRNSNew portfolio company
9th Feb 20157:00 amRNSScottish Enterprise Awards
5th Feb 20157:00 amRNSKey developments at portfolio company Alusid
2nd Feb 20157:00 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSPortfolio company Nandi Proteins featured on BBC
29th Dec 201411:44 amRNSResult of AGM
4th Dec 20147:00 amRNSPosting of Annual Report & Notice of AGM
1st Dec 20147:00 amRNSFinal Results
26th Nov 20147:00 amRNSNew spin-out company
17th Nov 20147:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.